Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2025-11-05 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺（白云霞）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for Shenzhen Huitai Medical Devices Co., Ltd. It details the candidate's qualifications, compliance with regulatory requirements, and commitment to independence and duties. There is no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filing in the typical sense. This document is related to board/management information specifically about a director candidate's qualifications and commitments. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a standalone declaration by a director candidate.
2025-11-05 Chinese
独立董事候选人声明与承诺（李光）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for Shenzhen Huitai Medical Devices Co., Ltd. It details the candidate's qualifications, compliance with regulatory requirements, and commitments related to the role of an independent director. There is no financial data, no report or announcement of financial results, no voting results, no management changes, or other typical financial or regulatory filings. This document is a formal statement related to board/management information, specifically concerning the nomination and qualifications of a board member candidate. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on the candidate's declaration, not a report or announcement of a report publication.
2025-11-05 Chinese
独立董事候选人声明与承诺（孙乐非）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for Shenzhen Huitai Medical Devices Co., Ltd. It details the candidate's qualifications, compliance with relevant laws and regulations, and commitment to independence and duties as an independent director. There is no financial data, no report or announcement of financial results, no voting results, no management changes, or other typical financial or regulatory filings. This type of document is related to board/management information, specifically concerning the nomination and qualifications of a board member. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing, but a formal statement by a board candidate.
2025-11-05 Chinese
董事会提名委员会关于董事候选人的审查意见
Board/Management Information Classification · 100% confidence The document is a formal opinion from the Board Nomination Committee regarding the qualifications and nomination of candidates for the company's board of directors. It reviews the candidates' compliance with relevant laws and regulations and confirms their eligibility and qualifications. There is no financial data, no mention of annual or quarterly reports, no voting results, no legal proceedings, and no other types of filings. This document pertains specifically to board/management information, particularly about board nominations and candidate qualifications. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short but contains substantive content about board nominations, not just an announcement or notice.
2025-11-05 Chinese
关于召开2025年第三次临时股东会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2025 third extraordinary shareholders' meeting (临时股东会) of Shenzhen Huitai Medical Devices Co., Ltd. It includes information about the meeting date, voting methods, agenda items (mainly board of directors election), voting procedures, attendance, and proxy forms. There is no financial data, earnings, or audit information. It is not a report but a formal announcement and notice for shareholders to participate in the meeting and vote. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document is over 5,000 characters and contains detailed meeting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the classification is AGM Information (AGM-R) with high confidence.
2025-11-05 Chinese
关于增加2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding an increase in the estimated amount of daily related-party transactions for the year 2025. It details the nature of the transactions, the related parties involved, the approval process by the board and independent directors, and the impact on the company. The document is a formal disclosure about related-party transactions and their expected increase, including financial figures and governance approvals. It is not a full financial report, audit report, or earnings release, nor is it a call transcript or management discussion. It is a regulatory announcement about related-party transactions, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance disclosure under stock exchange rules.
2025-10-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.